The aim of this study was to determine the immunogenicity of recombinant hepatitis B vaccine when administered intramuscularly to premature infants. Ninety percent of preterm infants responded to the hepatitis B vaccine when the first dose of vaccine was given just before hospital discharge. This study is now closed, and the data are being analyzed.
Showing the most recent 10 out of 455 publications